La 4’-Epi-Doxorubicina Nei Tumori Vescicali E Prostatici in Stadio Avanzato: Dati Definitivi

Arcamone F. , Penco S. , Vigevani A. : Adriamycin: new chemical development and analogs. Cancer Chem. Rep., 6; 123–129 (1975).

Arcamone F. , Penco S. , Vigevani A. , Redaelli S. , Franchi G. , Di Marco A. , Casazza A. M. , Dasdia T. , Formelli F. , Necco A. , Soranzo C. : Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone. J. Med. Chem., 18; 703–707 (1975).

Broggini M. , Colombo T. , Martini A. , Donelli M. G. : Studies on the comparative distribution and biliary excretion of doxorubicin and 4’-epi-doxorubicin in mice and rats. Cancer Treat. Rep., 64; 897–904 (1980).

Camaggi C. M. , Strocchi E. , Tamassia V. , Martoni A. , Giovannini M. , Iafelice G. , Canova N. , Marraro D. , Martini A. , Pannuti F. : Pharmacokinetics studies of 4’-epi-doxorubicin in cancer patients with normal and impaired renal function and with hepatic metastases. Cancer Treat. Rep., 66; 1819–1824 (1982).

Casazza A. M. , Di Marco A. , Bertazzoli C. , Formelli F. : Antitumor activity, toxicity and pharmacological properties of 4’-epi-adriamycin. In «Current Chemotherapy». American Society for Microbiology, International Society of Chemotherapy, 1257–1260, 1978.

Casazza A. M. : Experimental evaluation of anthracycline analogs. Cancer Treat. Rep., 63; 835–844 (1979).

Di Marco A. , Casazza A. M. , Gambetta R. , Supino R. , Zunino F. : Relationship between activity and aminosugar stereochemistry of daunorubicin and adriamycin derivatives. Cancer Res., 36; 1962–1966 (1976).

Kolaric K. , Potrebica V. , Cervek J. : Phase II clinical trial of 4’-epi-doxorubicin in metastatic solid tumors. J. Cancer Res. Clin. Oncol., 1982.

Martini A. , Isetta A. M. , Moro E. , Natale N. , Piazza E. : Studio farmacocinetico nell'uomo sulla 4’-epi-doxorubicina in confronto a doxorubicina. Tumori, 66; supplemento A., Abstract 40.

Natale N. , Brambilla M. , Luchini S. , Martini A. , Moro E. , Pacciarini M. A. , Vago G. , Trabattoni A. : 4’-epi-doxorubicin and doxorubicin: toxicity and pharmacokinetics in cancer patients. 12^th Intern. Congr. Chemother., abstract 348, p. 114. Florence 1981.

O'Bryan R. M. , Luce J. K. , Talley R. W. , Gottlieb J. A. , Baker L. H. , Bonadonna G. : Phase II evaluation of adriamycin in human neoplasia. Cancer, 32; 1–8 (1973).

Pannuti F. , Martoni A. , Givannini M. , Iafelice G. , Burroni P. , Strocchi E. , Bellanova B. , Monetti M. , Rossini G. , Tarquini M. , Toschi G. P. : 4’-epi-adriamycin: a phase II clinical study. 12^th Intern. Congr. Chemother., Abstract 350, p. 115, Florence, 19-24 July 1981.

Pavone-Macaluso M. , Tripi M. , Rizzo F. P. , Di Trapani D. , Candela B. , Raineri A. : A preliminary experience with 4’-epi-doxorubicin in bladder cancer. 13^th Intern. Congr. Chemother., Abstract SE 12.1.7/A 11, 114-117, Vienna, 28 Aug.-2 Sept. 1983.

Plumbridge T. W. , Brown J. R. : Studies on the mode of interaction of 4’-epi-doxorubicin and 4-demethoxydaunomycin with DNA. Biochem. Pharmacol., 27; 1881–1882 (1978).

Tripi M. , Panarisi S. , Rizzo F. P. , Di Trapani D. , Pavone-Macaluso M. : La 4’-epi-doxorubicina nei carcinomi vescicali e prostatici in stadio avanzato. Risultati preliminari. Atti I° Conv. Soc. Siculo-Calabra Urol., p. 109–119, Cefalù, 9-10 aprile 1983.